These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 11916535)

  • 1. Alteration of drug biotransformation and elimination during infection and inflammation.
    Renton KW
    Pharmacol Ther; 2001; 92(2-3):147-63. PubMed ID: 11916535
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytochrome P450 regulation and drug biotransformation during inflammation and infection.
    Renton KW
    Curr Drug Metab; 2004 Jun; 5(3):235-43. PubMed ID: 15180493
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Important role of proinflammatory cytokines/other endogenous substances in drug-induced hepatotoxicity: depression of drug metabolism during infections/inflammation states, and genetic polymorphisms of drug-metabolizing enzymes/cytokines may markedly contribute to this pathology.
    Prandota J
    Am J Ther; 2005; 12(3):254-61. PubMed ID: 15891270
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation of drug metabolism and disposition during inflammation and infection.
    Renton KW
    Expert Opin Drug Metab Toxicol; 2005 Dec; 1(4):629-40. PubMed ID: 16863429
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatic drug metabolism and immunostimulation.
    Renton KW
    Toxicology; 2000 Jan; 142(3):173-8. PubMed ID: 10667888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Regulation of cytochrome p450 by inflammatory mediators: why and how?
    Morgan ET
    Drug Metab Dispos; 2001 Mar; 29(3):207-12. PubMed ID: 11181485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect and clinical consequences of hypoxia on cytochrome P450, membrane carrier proteins activity and expression.
    du Souich P; Fradette C
    Expert Opin Drug Metab Toxicol; 2011 Sep; 7(9):1083-100. PubMed ID: 21619472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CYP2C8 and CYP3A4 are the principal enzymes involved in the human in vitro biotransformation of the insulin secretagogue repaglinide.
    Bidstrup TB; Bjørnsdottir I; Sidelmann UG; Thomsen MS; Hansen KT
    Br J Clin Pharmacol; 2003 Sep; 56(3):305-14. PubMed ID: 12919179
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Steroid hormone biotransformation and xenobiotic induction of hepatic steroid metabolizing enzymes.
    You L
    Chem Biol Interact; 2004 Apr; 147(3):233-46. PubMed ID: 15135080
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic cytochrome P450 down-regulation during aseptic inflammation in the mouse is interleukin 6 dependent.
    Siewert E; Bort R; Kluge R; Heinrich PC; Castell J; Jover R
    Hepatology; 2000 Jul; 32(1):49-55. PubMed ID: 10869288
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interleukin-1beta, interleukin-6, tumour necrosis factor-alpha and interferon-gamma released by a viral infection and an aseptic inflammation reduce CYP1A1, 1A2 and 3A6 expression in rabbit hepatocytes.
    Bleau AM; Maurel P; Pichette V; Leblond F; du Souich P
    Eur J Pharmacol; 2003 Jul; 473(2-3):197-206. PubMed ID: 12892839
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biotransformation of parathion in human liver: participation of CYP3A4 and its inactivation during microsomal parathion oxidation.
    Butler AM; Murray M
    J Pharmacol Exp Ther; 1997 Feb; 280(2):966-73. PubMed ID: 9023313
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pretranslational down-regulation of cytochromes P450 2C11 and 3A2 in male rat liver by tumor necrosis factor alpha.
    Nadin L; Butler AM; Farrell GC; Murray M
    Gastroenterology; 1995 Jul; 109(1):198-205. PubMed ID: 7797018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatic and central nervous system cytochrome P450 are down-regulated during lipopolysaccharide-evoked localized inflammation in brain.
    Renton KW; Nicholson TE
    J Pharmacol Exp Ther; 2000 Aug; 294(2):524-30. PubMed ID: 10900228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulation of the hepatic cytochrome P450 by an acute inflammatory reaction: implication of mediators in human and animal serum and in the liver.
    El-Kadi AO; Maurice H; Ong H; du Souich P
    Br J Pharmacol; 1997 Jul; 121(6):1164-70. PubMed ID: 9249253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elimination of major side effects due to ROS of therapeuticals through biotransformation control of the 57 cytochromes P450 isoenzymes.
    Wiseman A
    Med Hypotheses; 2005; 64(4):802-5. PubMed ID: 15694700
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Narcotic drugs change the expression of cytochrome P450 2E1 and 2C6 and other activities of carcinogen-metabolizing enzymes in the liver of male mice.
    Sheweita SA
    Toxicology; 2003 Sep; 191(2-3):133-42. PubMed ID: 12965116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potential role of cerebral cytochrome P450 in clinical pharmacokinetics: modulation by endogenous compounds.
    Gervasini G; Carrillo JA; Benitez J
    Clin Pharmacokinet; 2004; 43(11):693-706. PubMed ID: 15301574
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene-specific effects of inflammatory cytokines on cytochrome P450 2C, 2B6 and 3A4 mRNA levels in human hepatocytes.
    Aitken AE; Morgan ET
    Drug Metab Dispos; 2007 Sep; 35(9):1687-93. PubMed ID: 17576808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of cytochrome P450 regulation by inflammatory mediators.
    Morgan ET; Li-Masters T; Cheng PY
    Toxicology; 2002 Dec; 181-182():207-10. PubMed ID: 12505312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.